Cargando…

Metabolic Aspects of Palladium(II) Potential Anti-Cancer Drugs

This mini-review reports on the existing knowledge of the metabolic effects of palladium [Pd(II)] complexes with potential anticancer activity, on cell lines and murine models. Most studies have addressed mononuclear Pd(II) complexes, although increasing interest has been noted in bidentate complexe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carneiro, Tatiana J., Martins, Ana S., Marques, M. Paula M., Gil, Ana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586886/ https://www.ncbi.nlm.nih.gov/pubmed/33154950 http://dx.doi.org/10.3389/fonc.2020.590970

Ejemplares similares

Response of Osteosarcoma Cell Metabolism to Platinum and Palladium Chelates as Potential New Drugs
por: Martins, Ana S., et al.
Publicado: (2021)

Novel Insights into Mice Multi-Organ Metabolism upon Exposure to a Potential Anticancer Pd(II)-Agent
por: Carneiro, Tatiana J., et al.
Publicado: (2021)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs, volume II
por: Yan, Miao, et al.
Publicado: (2023)

Antiandrogen and Antimicrobial Aspects of Coordination Compounds of Palladium(II), Platinum(II) and Lead(II)
por: Singh, R. V., et al.
Publicado: (2001)

Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy
por: Araújo, Rita, et al.
Publicado: (2022)

Metabolic Impact of Anticancer Drugs Pd(2)Spermine and Cisplatin on the Brain of Healthy Mice
por: Carneiro, Tatiana J., et al.
Publicado: (2022)

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
por: Bapiro, Tashinga E., et al.
Publicado: (2022)

Companion Diagnostics for Targeted Cancer Drugs – Clinical and Regulatory Aspects
por: Olsen, Dana, et al.
Publicado: (2014)

Fertility Inhibitor Heterobimetallic Complexes of Platinum(II) and Palladium(II): Synthetic, Spectroscopic and Antimicrobial Aspects
por: Sharma, Kripa, et al.
Publicado: (2000)

Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma
por: Espíndola, Kaio Murilo Monteiro, et al.
Publicado: (2019)

Effect of Metabolic Syndrome and Individual Components on Colon Cancer Characteristics and Prognosis
por: Silva, Ana, et al.
Publicado: (2021)

Impact of the Pd(2)Spm (Spermine) Complex on the Metabolism of Triple-Negative Breast Cancer Tumors of a Xenograft Mouse Model
por: Carneiro, Tatiana J., et al.
Publicado: (2021)

Preclinical Pharmacokinetics and Biodistribution of Anticancer Dinuclear Palladium(II)-Spermine Complex (Pd(2)Spm) in Mice
por: Vojtek, Martin, et al.
Publicado: (2021)

Editorial: Anti-cancer drug delivery: lipid-based nanoparticles
por: Alkilany, Alaaldin M., et al.
Publicado: (2023)

Effect of Pd(2)Spermine on Mice Brain-Liver Axis Metabolism Assessed by NMR Metabolomics
por: Carneiro, Tatiana J., et al.
Publicado: (2022)

Pathophysiological aspects of nephropathy caused by non-steroidal anti-inflammatory drugs
por: Lucas, Guillherme Nobre Cavalcanti, et al.
Publicado: (2018)

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy
por: Kanikarla-Marie, Preeti, et al.
Publicado: (2018)

The Influence of Metabolism on Drug Response in Cancer
por: Zaal, Esther A., et al.
Publicado: (2018)

Editorial: Altered expression of proteins in cancer: function and potential therapeutic targets, volume II
por: Pessoa, João, et al.
Publicado: (2023)

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing
por: Kalra, Rajkumar Singh, et al.
Publicado: (2022)

Editorial: Therapeutic drug monitoring and clinical toxicology of anti-cancer drugs
por: Liu, Yao, et al.
Publicado: (2022)

Multi-Organ NMR Metabolomics to Assess In Vivo Overall Metabolic Impact of Cisplatin in Mice
por: Carneiro, Tatiana J., et al.
Publicado: (2019)

MiRNAs as Anti-Angiogenic Adjuvant Therapy in Cancer: Synopsis and Potential
por: Lahooti, Behnaz, et al.
Publicado: (2021)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer—A Clinicopathological Series
por: Alves, Marclesson, et al.
Publicado: (2021)

Metal chelates as anti-cancer agents. II cytotoxic action of palladium and platinum complexes of 6-mercaptopurine and thioguanine.
por: Das, M., et al.
Publicado: (1978)

Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation
por: Rodrigues, Jorge, et al.
Publicado: (2023)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Molecular and Metabolic Reprogramming: Pulling the Strings Toward Tumor Metastasis
por: Hipólito, Ana, et al.
Publicado: (2021)

Proteasomes and Several Aspects of Their Heterogeneity Relevant to Cancer
por: Morozov, Alexey V., et al.
Publicado: (2019)

COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs
por: Gurpinar, Evrim, et al.
Publicado: (2013)

Editorial: New insights into the mechanisms of resistance to anti-cancer drugs
por: Bertoni, Francesco, et al.
Publicado: (2022)

Relationship between metabolic reprogramming and drug resistance in breast cancer
por: Lv, Linlin, et al.
Publicado: (2022)

Cancer Stem Cell Metabolism and Potential Therapeutic Targets
por: Snyder, Vusala, et al.
Publicado: (2018)

Editorial: Redox Potential and Metabolic Behavior in Gastrointestinal Cancers
por: Biagioni, Alessio, et al.
Publicado: (2022)

The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
por: Barillari, Giovanni
Publicado: (2020)

Alterations of Lipid Metabolism in Cancer: Implications in Prognosis and Treatment
por: Fernández, Lara P., et al.
Publicado: (2020)

Dibromidobis(triphenylarsine)palladium(II)
por: Kirsten, Leo, et al.
Publicado: (2009)

Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy
por: Wegiel, Barbara, et al.
Publicado: (2018)

Preparation of Palladium(II) Ion-Imprinted Polymeric Nanospheres and Its Removal of Palladium(II) from Aqueous Solution
por: Tao, Hu-Chun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jutv1i67l8f4of89ri0496v4ct